Analytics

Articles

Corning will feature its 3D bioprinting technology and tools to support 3D cell culture at booth #1029 during the SLAS 2018 conference on Feb. 3-7, 2018 in San Diego, CA.

Corning Showcases 3D Cell Culture Technologies at SLAS 2018

Comecar will provide cell culture equipment for biopharmaceutical company CO.DON AG's new production site in Leipzig, Germany.

Comecar in $12-Million Deal to Equip German Cell Culture Lab

The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.

Takeda to Acquire TiGenix

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Graham Reynolds, vice-president and general manager, Global Biologics at West Pharmaceutical Services, Inc., shares insights on key considerations when developing a biologic drug product in a prefilled syringe. 

Formulation and Functional Considerations for Delivering Biologics in Prefilled Syringes

The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.

Pfizer and Sangamo Partner on Gene Therapy for Lou Gehrig's Disease

The companies aim to discover and develop locked nucleic acid oligonucleotides as orally available therapies for treating inflammatory bowel diseases.

Boehringer Ingelheim and Roche Collaborate on Treatment for Inflammatory Bowel Diseases

The development of new packaging solutions that are fit for drugs of the future requires close collaboration between the pharmaceutical manufacturer and its packaging suppliers and machine vendors.

Elucidating Parenteral Packaging Requirements for Future Drugs

Guy Bouvier, guybouvier06FR@gmail.com, is nonclinical coordination and evaluation manager at Nestle Skin Health. 

Jean-Guy Boiteau is head of process research and development at Nestle Skin Health. 

Amandine Gras is product development coordinator and CMC expert at Nestle Skin Health. 

Anne-Pascale Luzy is head of in vitro toxicology at Nestle Skin Health.

Jean-Pierre Etchegaray is pharmaceutical development expert at Nestle Skin Health.

The authors offer recommendations for permissible daily exposures and concentration limits of elemental impurities for dermal drug products.

Determination of Dermal PDE for Pharmaceutical Products

FDA has approved a new gene therapy for treating patients born with a rare, inherited vision loss.

FDA Approves Spark Therapeutics’ Gene Therapy for Inherited Vision Loss

MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.

Drug Substance Analysis